Tag: AIMNASH
-
AIM-NASH: FDA Approves Groundbreaking AI System for Liver Sickness Biopsy Analysis
The FDA has formally permitted the first AI instrument to help with liver sickness drug trials, and it is designed to make finding out liver biopsies for MASH faster, further fixed, and less complicated for pathologists to utilize in scientific evaluation.“The U.S. Meals and Drug Administration (FDA) has licensed the first AI drug development instrument,…